Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of polyglutamine disorders: aggregation revisited.

Andrej Michalik1, Christine Van Broeckhoven

  • 1Department of Molecular Genetics, Flanders Interuniversity Institute of Biotechnology, University of Antwerp, Antwerpen, Belgium.

Human Molecular Genetics
|September 25, 2003
PubMed
Summary

Polyglutamine expansion causes neurodegenerative diseases like Huntington's. Whether toxic protein aggregates or soluble forms damage neurons is debated, impacting understanding of disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare ABCA7 mutations in Alzheimer's disease and cerebral amyloid angiopathy pathology.

Neurobiology of aging·2026
Same author

Investigation of the role of miRNA variants in neurodegenerative brain diseases.

Frontiers in genetics·2025
Same author

Correction to: Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins.

Acta neuropathologica·2024
Same author

The <i>SORL1</i> p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

American journal of human genetics·2024
Same author

Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method.

Alzheimer's research & therapy·2024

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Expansion of CAG trinucleotide repeats leads to polyglutamine diseases.
  • These disorders are progressive, late-onset neurodegenerative conditions.
  • Polyglutamine toxicity is context-dependent, influencing disease presentation.

Purpose of the Study:

  • To review and reconcile controversies surrounding polyglutamine aggregation in neurodegenerative diseases.
  • To explore the role of protein context in modulating polyglutamine toxicity.
  • To discuss the pathogenic mechanisms of polyglutamine disorders.

Main Methods:

  • Literature review and synthesis of existing research.
  • Analysis of studies investigating soluble versus aggregated forms of disease proteins.

Related Experiment Videos

  • Comparison of clinical and pathological features across different polyglutamine disorders.

    • Main Results:

    • Polyglutamine expansion triggers dominant gain-of-function neurotoxicity.
    • Protein context influences the specific clinical and pathological manifestations.
    • The role of aggregation in pathogenesis is debated: aggregates may be toxic, harmless, or protective.

    Conclusions:

    • The exact role of polyglutamine aggregates in neurodegenerative disease pathogenesis remains controversial.
    • Understanding whether soluble or aggregated forms are toxic is crucial for therapeutic strategies.
    • Reconciling conflicting evidence is key to advancing research on polyglutamine disorders.